{
    "Trade/Device Name(s)": [
        "Liquichek Tumor Markers Control"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K071675",
    "Predicate Device Reference 510(k) Number(s)": [
        "K011579"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "July 31, 2007",
    "Summary Letter Received Date": "June 19, 2007",
    "Submission Date": "June 15, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "cancer molecular",
        "immunology"
    ],
    "Analyte(s)": [
        "Alpha Fetoprotein",
        "Beta-2-Microglobulin",
        "CA 15-3",
        "CA 19-9",
        "CA 27.29",
        "CA 125",
        "CEA",
        "Ferritin",
        "hCG (\u03b2-hCG, Total hCG, Intact hCG)",
        "PAP",
        "Prolactin",
        "Total PSA",
        "Free PSA",
        "Thyroglobulin",
        "Insulin-like Growth Factor-I (IGF-1)"
    ],
    "Specimen Type(s)": [
        "Human serum",
        "Animal serum albumin"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Laboratories Liquichek Tumor Markers Control as an assayed quality control material for monitoring precision of laboratory testing procedures for multiple tumor marker analytes.",
    "Indications for Use Summary": "Liquichek Tumor Markers Control is intended for use as an assayed quality control material to monitor the precision of laboratory testing procedures for the analytes listed in the package insert.",
    "fda_folder": "Clinical Chemistry"
}